DKK 248.2
(4.9%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 21.2 Billion DKK | -0.41% |
2022 | 21.29 Billion DKK | 26.16% |
2021 | 16.87 Billion DKK | 23.67% |
2020 | 13.64 Billion DKK | -3.57% |
2019 | 14.15 Billion DKK | 30.13% |
2018 | 10.87 Billion DKK | 23.75% |
2017 | 8.78 Billion DKK | 2.41% |
2016 | 8.58 Billion DKK | 8.77% |
2015 | 7.89 Billion DKK | 40.02% |
2014 | 5.63 Billion DKK | 6.78% |
2013 | 5.27 Billion DKK | 11.85% |
2012 | 4.71 Billion DKK | 8.66% |
2011 | 4.34 Billion DKK | -0.01% |
2010 | 4.34 Billion DKK | 30.63% |
2009 | 3.32 Billion DKK | -1.82% |
2008 | 3.38 Billion DKK | 2.88% |
2007 | 3.29 Billion DKK | 33.58% |
2006 | 2.46 Billion DKK | 15.29% |
2005 | 2.13 Billion DKK | 19.02% |
2004 | 1.79 Billion DKK | 20.27% |
2003 | 1.49 Billion DKK | -4.54% |
2002 | 1.56 Billion DKK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 22.86 Billion DKK | 0.0% |
2024 Q1 | 22.86 Billion DKK | 7.83% |
2023 Q3 | 21.2 Billion DKK | 1.75% |
2023 Q1 | 20.84 Billion DKK | -2.12% |
2023 Q4 | 21.2 Billion DKK | 0.0% |
2023 FY | 21.2 Billion DKK | -0.41% |
2023 Q2 | 20.84 Billion DKK | 0.0% |
2022 Q3 | 21.29 Billion DKK | 11.2% |
2022 FY | 21.29 Billion DKK | 26.16% |
2022 Q2 | 19.15 Billion DKK | 0.0% |
2022 Q4 | 21.29 Billion DKK | 0.0% |
2022 Q1 | 19.15 Billion DKK | 13.46% |
2021 Q4 | 16.87 Billion DKK | 0.0% |
2021 FY | 16.87 Billion DKK | 23.67% |
2021 Q3 | 16.87 Billion DKK | 6.94% |
2021 Q1 | 15.78 Billion DKK | 15.64% |
2021 Q2 | 15.78 Billion DKK | 0.0% |
2020 Q4 | 13.64 Billion DKK | 0.0% |
2020 Q1 | 14.61 Billion DKK | 3.29% |
2020 Q2 | 14.61 Billion DKK | 0.0% |
2020 Q3 | 13.64 Billion DKK | -6.64% |
2020 FY | 13.64 Billion DKK | -3.57% |
2019 FY | 14.15 Billion DKK | 30.13% |
2019 Q4 | 14.15 Billion DKK | 0.0% |
2019 Q3 | 14.15 Billion DKK | 7.52% |
2019 Q2 | 13.16 Billion DKK | 0.0% |
2019 Q1 | 13.16 Billion DKK | 21.03% |
2018 Q1 | 10.28 Billion DKK | 16.98% |
2018 Q3 | 10.87 Billion DKK | 5.79% |
2018 Q4 | 10.87 Billion DKK | 0.0% |
2018 FY | 10.87 Billion DKK | 23.75% |
2018 Q2 | 10.28 Billion DKK | 0.0% |
2017 Q2 | 8.83 Billion DKK | 0.0% |
2017 Q4 | 8.78 Billion DKK | 0.0% |
2017 FY | 8.78 Billion DKK | 2.41% |
2017 Q1 | 8.83 Billion DKK | 2.94% |
2017 Q3 | 8.78 Billion DKK | -0.51% |
2016 Q1 | 8.24 Billion DKK | 4.46% |
2016 FY | 8.58 Billion DKK | 8.77% |
2016 Q4 | 8.58 Billion DKK | 0.0% |
2016 Q3 | 8.58 Billion DKK | 4.13% |
2016 Q2 | 8.24 Billion DKK | 0.0% |
2015 Q2 | 6.01 Billion DKK | 0.0% |
2015 Q4 | 7.89 Billion DKK | 0.0% |
2015 Q3 | 7.89 Billion DKK | 31.26% |
2015 Q1 | 6.01 Billion DKK | 6.67% |
2015 FY | 7.89 Billion DKK | 40.02% |
2014 Q1 | 5.37 Billion DKK | 1.88% |
2014 FY | 5.63 Billion DKK | 6.78% |
2014 Q4 | 5.63 Billion DKK | 0.0% |
2014 Q3 | 5.63 Billion DKK | 4.82% |
2014 Q2 | 5.37 Billion DKK | 0.0% |
2013 Q2 | 5.2 Billion DKK | 0.0% |
2013 FY | 5.27 Billion DKK | 11.85% |
2013 Q4 | 5.27 Billion DKK | 0.29% |
2013 Q3 | 5.26 Billion DKK | 1.08% |
2013 Q1 | 5.2 Billion DKK | 10.34% |
2012 FY | 4.71 Billion DKK | 8.66% |
2012 Q2 | 4.55 Billion DKK | 285.93% |
2012 Q3 | 4.71 Billion DKK | 3.65% |
2012 Q4 | 4.71 Billion DKK | 0.0% |
2012 Q1 | 1.17 Billion DKK | -72.84% |
2011 Q1 | 1.08 Billion DKK | -75.0% |
2011 Q3 | 1.08 Billion DKK | -73.5% |
2011 Q4 | 4.34 Billion DKK | 300.0% |
2011 FY | 4.34 Billion DKK | -0.01% |
2011 Q2 | 4.09 Billion DKK | 277.34% |
2010 Q3 | 1.08 Billion DKK | -72.79% |
2010 FY | 4.34 Billion DKK | 30.63% |
2010 Q1 | 1.08 Billion DKK | 30.63% |
2010 Q2 | 3.99 Billion DKK | 267.55% |
2010 Q4 | 4.34 Billion DKK | 300.0% |
2009 Q1 | 831.07 Million DKK | -1.82% |
2009 Q3 | 831.07 Million DKK | 0.0% |
2009 Q2 | 831.07 Million DKK | 0.0% |
2009 FY | 3.32 Billion DKK | -1.82% |
2009 Q4 | 831.07 Million DKK | 0.0% |
2008 Q3 | 846.45 Million DKK | 0.0% |
2008 Q4 | 846.45 Million DKK | 0.0% |
2008 FY | 3.38 Billion DKK | 2.88% |
2008 Q1 | 846.45 Million DKK | 2.88% |
2008 Q2 | 846.45 Million DKK | 0.0% |
2007 Q1 | 822.74 Million DKK | 33.58% |
2007 Q3 | 822.74 Million DKK | 0.0% |
2007 FY | 3.29 Billion DKK | 33.58% |
2007 Q4 | 822.74 Million DKK | 0.0% |
2007 Q2 | 822.74 Million DKK | 0.0% |
2006 Q3 | 615.92 Million DKK | 0.0% |
2006 Q4 | 615.92 Million DKK | 0.0% |
2006 Q2 | 615.92 Million DKK | 0.0% |
2006 Q1 | 615.92 Million DKK | 15.29% |
2006 FY | 2.46 Billion DKK | 15.29% |
2005 Q1 | 534.22 Million DKK | 19.02% |
2005 Q3 | 534.22 Million DKK | 0.0% |
2005 Q2 | 534.22 Million DKK | 0.0% |
2005 Q4 | 534.22 Million DKK | 0.0% |
2005 FY | 2.13 Billion DKK | 19.02% |
2004 FY | 1.79 Billion DKK | 20.27% |
2004 Q4 | 448.84 Million DKK | 0.0% |
2004 Q3 | 448.84 Million DKK | 0.0% |
2004 Q1 | 448.84 Million DKK | 20.27% |
2004 Q2 | 448.84 Million DKK | 0.0% |
2003 Q2 | 373.2 Million DKK | 0.0% |
2003 FY | 1.49 Billion DKK | -4.54% |
2003 Q1 | 373.2 Million DKK | -4.54% |
2003 Q3 | 373.2 Million DKK | 0.0% |
2003 Q4 | 373.2 Million DKK | 0.0% |
2002 Q1 | 390.94 Million DKK | 0.0% |
2002 Q2 | 390.94 Million DKK | 0.0% |
2002 FY | 1.56 Billion DKK | 0.0% |
2002 Q3 | 390.94 Million DKK | 0.0% |
2002 Q4 | 390.94 Million DKK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ambu A/S | 1.46 Billion DKK | -1346.658% |
ChemoMetec A/S | 111.35 Million DKK | -18945.053% |
GN Store Nord A/S | 21.05 Billion DKK | -0.727% |
Scandinavian Medical Solutions A/S | 89.51 Million DKK | -23592.677% |
ViroGates A/S | 7.54 Million DKK | -280875.093% |